Search Results
27 results found-
Rank Name Units % Units 1 HSBC CUSTODY NOMINEES (AUSTRALIA) LIMITED 158,208,692 32.80 2 J P MORGAN NOMINEES AUSTRALIA PTY LIMITED 81,652,973 16.93 3 CITICORP NOMINEES PTY LIMITED 45,017,523 9.33 4 NATIONAL NOMINEES LIMITED 15,121,161 3.13 5 BNP PARIBAS NOMS PTY LTD
12,608,974 2.61 6 BNP PARIBAS NOMINEES PTY LTD 4,832,402 1.00 7 CITICORP NOMINEES PTY LIMITED 4,734,581 0.98 8 HSBC CUSTODY NOMINEES (AUSTRALIA) LIMITED 3,278,217 0.68 9 NETWEALTH INVESTMENTS LIMITED 2,568,812 0.53 10 AUSTRALIAN FOUNDATION INVESTMENT COMPANY LIMITED 2,239,500 0.46 11 BNP PARIBAS NOMINEES PTY LTD HUB24 CUSTODIAL SERV LTD 2,163,373 0.45 12 CUSTODIAL SERVICES LIMITED 1,665,903 0.35 13 SOLIUM NOMINEES (AUSTRALIA) PTY LTD 1,574,635 0.33 14 ARGO INVESTMENTS LIMITED 1,311,509 0.27 15 BNP PARIBAS NOMS (NZ) LTD 898,418 0.19 16 MUTUAL TRUST PTY LTD 891,059 0.18 17 D W S NOMINEES PTY LTD 793,208 0.16 18 HSBC CUSTODY NOMINEES (AUSTRALIA) LIMITED - A/C 2 750,247 0.16 19 BNP PARIBAS NOMINEES PTY LTD 726,200 0.15 20 SOLIUM NOMINEES (AUSTRALIA) PTY LTD 676,661 0.14 Totals:
https://www.csl.com/-/media/shared/documents/annual-report/csl-annual-report-2023.pdf -
Other Long Short Term Benefits Post-Employment Term Share Based Payments14 Non- Performance Restricted Cash Salary Cash Bonus Monetary Performance Share Units Share Units % Performance Executive Year13 and Fees US$15 US$16 US$17 Super US$ LSL US$ Rights US$ Options US$ US$ US$ EDIP US$18, 19 Total US$ Related P Perreault - 2020 1,676,919 2,477,746 52,404 19,950 - 717,831 473,426 5,474,555 - 223,961 11,116,792 84% CEO and Managing Director 2019 1,676,922 1,979,386 48,880 19,600 - 1,356,333 887,634 4,120,925 - 721,358 10,811,038 84% A Cuthbertson - 2020 714,704 699,030 29,944 16,808 16,531 158,047 - 1,114,393 - 47,754 2,797,211 72% Chief Scientific Officer 2019 734,862 563,225 29,944 17,948 28,810 262,534 - 864,952 - 146,773 2,649,048 69% D Lamont - 2020 887,558 901,581 14,747 16,808 20,979 162,128 - 937,367 - 45,216 2,986,384 69% Chief Financial Officer 2019 899,222 722,033 14,747 17,948 24,062 390,393 - 727,202 - 143,391 2,938,998 67% P McKenzie 2020 999,747 1,164,765 552,870 22,243 - - - 2,817,245 1,274,105 - 6,830,975 77% Chief Operating Officer 2019 - - - - - - - - - - - -
https://www.csl.com/-/media/csl/documents/annual-report-docs/csl-ltd-annual-report-2020-full.pdf -
A ordinary course of trading in the Over-The-Counter (OTC) significant foreign shareholding is one where a foreign person market in the US.
https://www.csl.com/-/media/csl/documents/annual-report-docs/csl-ltd-annual-report-2019-full.pdf -
Dukoral Fucidin n Box jelly fish antivenom n Sea Snake antivenom Merck & Co. Inc. Gardasil n Stone fish antivenom H-B-Vax II M-M-R II Vaccines Pneumovax n Q-Vax® for the prevention of Q fever ProQuad n Q-Vax® Skin Test for the detection of Q fever antibodies RotaTeq Vaqta Varivax DIAGNOSTIC PRODUCTS Zostavax Seqirus develops, manufactures and markets in vitro diagnostic products for immunohaematology and snake venom detection.
https://www.csl.com/-/media/csl/documents/annual-report-docs/csl-ltd-annual-report-2016-full.pdf -
PaxVax Bera GmbH - Vivotif Oral - Box jelly fish antivenom iNova Pharmaceuticals Pty Ltd - Tetrabenazine - Sea Snake antivenom - Stone fish antivenom Valneva Inc. - Jespect, Dukoral Vaccines - Q-Vax® for the prevention of Q fever - Q-Vax® Skin Test for the detection of Q fever antibodies
https://www.csl.com/-/media/csl/documents/annual-report-docs/csl-ltd-annual-report-2017-full.pdf -
in the Over-The-Counter (OTC) market Unmarketable Parcels Minimum Parcel Size Holders Units in the US.
https://www.csl.com/-/media/csl/documents/annual-report-docs/csl-ltd-annual-report-2018-full.pdf -
The International Labour Organization further defines forced labour as work that is performed involuntarily and under the menace of any penalty.
https://www.csl.com/-/media/csl/documents/csl-statement-on-modern-slavery-2023.pdf -
Over the reporting period, CSL held a targeted and customised virtual training on modern slavery and forced labour awareness training and engagement session with leaders/decision-makers in the talent acquisition team across the Group.
https://medialib.csl.com/-/media/csl/documents/csl-statement-on-modern-slavery-2021.pdf -
Over the reporting period, CSL held a targeted and customised virtual training on modern slavery and forced labour awareness training and engagement session with leaders/decision-makers in the talent acquisition team across the Group.
https://www.csl.com/-/media/csl/documents/csl-statement-on-modern-slavery-2021.pdf -
CSL is focused on driving a responsible global mindset and creating an end-to-end operation that is scalable, from plasma collection through to delivery.
https://www.csl.com/sustainability/social/responsible-and-resilient-supply-chain